Catherine B.Schumacher
Partner
Securities & Fiduciary Duty Litigation
cschumacher@seyfarth.com
More About Kate
Kate focuses her practice on complex commercial litigation, securities and derivative litigation, M&A litigation and internal and government investigations. She has experience representing public and private companies and directors, officers and special committees in state and federal class action securities and derivative actions throughout the country, SEC investigations, civil and criminal Department of Justice investigations and states' Attorneys General investigations.
In the securities litigation area, Kate has represented a former officer and director of a global insurance company in federal securities class actions, shareholder derivative suits, an ERISA class action and attendant regulatory investigations, including a fraud suit brought under New York’s Martin Act; a global mining company in a federal securities class action alleging Section 14(a) and control person claims; members of the special committee of the board of directors of an entertainment company in a securities class action alleging 10(b)(5) and control person claims relating to a proposed going-private transaction; and a healthcare company in a case alleging breach of contract and breach of fiduciary duty, which included a trial under Delaware’s "books and records" statute.
In the commercial litigation area, Kate has represented clients in state and federal courts, as well as a lengthy American Arbitration Association arbitration, in disputes involving breach of contract, breach of fiduciary duty, conversion and copyright infringement claims.
Kate has been recognized for her excellence in the profession. She has been acknowledged for a number of years by Chambers for Securities’ Litigation. Crain’s New York Business Magazine (Crain Communications, Inc.) named Kate to its "40 Under 40" list in 2014 and Law360 (Portfolio Media, Inc.) identified Kate as one of "10 Securities Lawyers Under 40 to Watch" in 2010 and as a "Rising Star" in 2014. Kate frequently speaks on panels and writes on a range of topics relating to developments in securities litigation and commercial litigation.
In the securities litigation area, Kate has represented a former officer and director of a global insurance company in federal securities class actions, shareholder derivative suits, an ERISA class action and attendant regulatory investigations, including a fraud suit brought under New York’s Martin Act; a global mining company in a federal securities class action alleging Section 14(a) and control person claims; members of the special committee of the board of directors of an entertainment company in a securities class action alleging 10(b)(5) and control person claims relating to a proposed going-private transaction; and a healthcare company in a case alleging breach of contract and breach of fiduciary duty, which included a trial under Delaware’s "books and records" statute.
In the commercial litigation area, Kate has represented clients in state and federal courts, as well as a lengthy American Arbitration Association arbitration, in disputes involving breach of contract, breach of fiduciary duty, conversion and copyright infringement claims.
Kate has been recognized for her excellence in the profession. She has been acknowledged for a number of years by Chambers for Securities’ Litigation. Crain’s New York Business Magazine (Crain Communications, Inc.) named Kate to its "40 Under 40" list in 2014 and Law360 (Portfolio Media, Inc.) identified Kate as one of "10 Securities Lawyers Under 40 to Watch" in 2010 and as a "Rising Star" in 2014. Kate frequently speaks on panels and writes on a range of topics relating to developments in securities litigation and commercial litigation.
- JD, Fordham University School of Law
- BA, Boston College
English and Communications
Magna cum laude
- New York
- US District Court, Eastern District of New York
- US District Court, Southern District of New York
Related Services
Related News & Insights
-
Recognition
10/05/2023
Seyfarth Ranked Tier 1 Nationally for Labor & Employment in Benchmark Litigation 2023; 29 Seyfarth Lawyers Cited
-
Recognition
Sep 30, 2022
Seyfarth Earns Top Rankings in Benchmark Litigation 2022
-
Legal Update
May 5, 2022
The Grundfest Solution Works Again and Corporate Counsel of Public Companies Should Take Notice of the Upside of Federal Forum Selection Clauses
-
Webinar
Apr 27, 2022
Webinar Series - Commercial Litigation Outlook: Insights and Predictions for Litigation Trends in 2022
- Selected among the "Litigators of the Week" by The American Lawyer (2024)
- Recognized as a "Labor & Employment Star" by Benchmark Litigation (Euromoney Institutional Investor) (2021)
- Recognized as a "Future Star" by Benchmark Litigation (Euromoney Institutional Investor) (2020, 2023)
- Co-Author, "The Grundfest Solution Works Again and Corporate Counsel of Public Companies Should Take Notice of the Upside of Federal Forum Selection Clauses," Legal Update, Seyfarth Shaw LLP (May 5, 2022)
- Co-Author, "In the Wake of the Pandora’s Box Opened by the Supreme Court’s Cyan Decision, Court to Address Discovery Stay Question in State Securities Act Cases," Legal Update, Seyfarth Shaw LLP (July 7, 2021)
- Co-Author, "More Cannabis Industry Securities Suits Hit Dockets," Legal Update, Seyfarth Shaw LLP (May 25, 2021)
- Co-Author, "New York’s Disclosure Law and Other Laws and Regulatory Mandates Regarding Women on Corporate Boards," Legal Update, Seyfarth Shaw LLP (January 21, 2021)
- Co-Author, "Over 50 M&A Deals Have Been Challenged This Year by a Single Group of Lawyers," Legal Update, Seyfarth Shaw LLP (June 12, 2020)
- Co-Author, "Event-Driven Securities Litigation in the Age of COVID-19," Legal Update, Seyfarth Shaw LLP (June 11, 2020)
- Co-Author, "District Courts In New Jersey And New York Dismiss Securities Class Actions Against Life Science Companies Emphasizing the High Pleading Bar With Respect To Optimistic Forward-Looking Statements," Legal Update, Seyfarth Shaw LLP (May 5, 2020)
- Co-Author, "Ninth Circuit To Determine Applicability of Affiliated Ute Presumption of Reliance To Securities Fraud Actions," Legal Update, Seyfarth Shaw LLP (April 17, 2020)
- Co-Author, "Massachusetts District Court Dismisses Suit Against Pharma Company Finding That Optimistic Statements Regarding Drug Prospects Are Not Misleading Simply Because FDA Does Not Approve," Legal Update, Seyfarth Shaw LLP (April 14, 2020)
- Co-Presenter, "Commercial Litigation Outlook: Part 1: Insights and Predictions for Litigation Trends in 2022," Webinar Series, Seyfarth Shaw LLP (April 12, 2022)
- Panelist, "Crisis Management and Workplace Investigations Planning and Response," Webinar, Seyfarth Shaw LLP (September 30, 2021)
- Co-Presenter, "New Era, New Litigation: Lawsuits You Can Expect in the Post-Pandemic Environment," Webinar, Seyfarth Shaw LLP (July 22, 2020)
- Co-Presenter, "COVID-19 Legal Exposure for Public Companies and their Directors & Officers," Webinar, Seyfarth Shaw LLP (April 21, 2020)
More About Kate
Kate focuses her practice on complex commercial litigation, securities and derivative litigation, M&A litigation and internal and government investigations. She has experience representing public and private companies and directors, officers and special committees in state and federal class action securities and derivative actions throughout the country, SEC investigations, civil and criminal Department of Justice investigations and states' Attorneys General investigations.
In the securities litigation area, Kate has represented a former officer and director of a global insurance company in federal securities class actions, shareholder derivative suits, an ERISA class action and attendant regulatory investigations, including a fraud suit brought under New York’s Martin Act; a global mining company in a federal securities class action alleging Section 14(a) and control person claims; members of the special committee of the board of directors of an entertainment company in a securities class action alleging 10(b)(5) and control person claims relating to a proposed going-private transaction; and a healthcare company in a case alleging breach of contract and breach of fiduciary duty, which included a trial under Delaware’s "books and records" statute.
In the commercial litigation area, Kate has represented clients in state and federal courts, as well as a lengthy American Arbitration Association arbitration, in disputes involving breach of contract, breach of fiduciary duty, conversion and copyright infringement claims.
Kate has been recognized for her excellence in the profession. She has been acknowledged for a number of years by Chambers for Securities’ Litigation. Crain’s New York Business Magazine (Crain Communications, Inc.) named Kate to its "40 Under 40" list in 2014 and Law360 (Portfolio Media, Inc.) identified Kate as one of "10 Securities Lawyers Under 40 to Watch" in 2010 and as a "Rising Star" in 2014. Kate frequently speaks on panels and writes on a range of topics relating to developments in securities litigation and commercial litigation.
In the securities litigation area, Kate has represented a former officer and director of a global insurance company in federal securities class actions, shareholder derivative suits, an ERISA class action and attendant regulatory investigations, including a fraud suit brought under New York’s Martin Act; a global mining company in a federal securities class action alleging Section 14(a) and control person claims; members of the special committee of the board of directors of an entertainment company in a securities class action alleging 10(b)(5) and control person claims relating to a proposed going-private transaction; and a healthcare company in a case alleging breach of contract and breach of fiduciary duty, which included a trial under Delaware’s "books and records" statute.
In the commercial litigation area, Kate has represented clients in state and federal courts, as well as a lengthy American Arbitration Association arbitration, in disputes involving breach of contract, breach of fiduciary duty, conversion and copyright infringement claims.
Kate has been recognized for her excellence in the profession. She has been acknowledged for a number of years by Chambers for Securities’ Litigation. Crain’s New York Business Magazine (Crain Communications, Inc.) named Kate to its "40 Under 40" list in 2014 and Law360 (Portfolio Media, Inc.) identified Kate as one of "10 Securities Lawyers Under 40 to Watch" in 2010 and as a "Rising Star" in 2014. Kate frequently speaks on panels and writes on a range of topics relating to developments in securities litigation and commercial litigation.
- JD, Fordham University School of Law
- BA, Boston College
English and Communications
Magna cum laude
- New York
- US District Court, Eastern District of New York
- US District Court, Southern District of New York
Related Services
Related News & Insights
-
Recognition
10/05/2023
Seyfarth Ranked Tier 1 Nationally for Labor & Employment in Benchmark Litigation 2023; 29 Seyfarth Lawyers Cited
-
Recognition
Sep 30, 2022
Seyfarth Earns Top Rankings in Benchmark Litigation 2022
-
Legal Update
May 5, 2022
The Grundfest Solution Works Again and Corporate Counsel of Public Companies Should Take Notice of the Upside of Federal Forum Selection Clauses
-
Webinar
Apr 27, 2022
Webinar Series - Commercial Litigation Outlook: Insights and Predictions for Litigation Trends in 2022
- Selected among the "Litigators of the Week" by The American Lawyer (2024)
- Recognized as a "Labor & Employment Star" by Benchmark Litigation (Euromoney Institutional Investor) (2021)
- Recognized as a "Future Star" by Benchmark Litigation (Euromoney Institutional Investor) (2020, 2023)
- Co-Author, "The Grundfest Solution Works Again and Corporate Counsel of Public Companies Should Take Notice of the Upside of Federal Forum Selection Clauses," Legal Update, Seyfarth Shaw LLP (May 5, 2022)
- Co-Author, "In the Wake of the Pandora’s Box Opened by the Supreme Court’s Cyan Decision, Court to Address Discovery Stay Question in State Securities Act Cases," Legal Update, Seyfarth Shaw LLP (July 7, 2021)
- Co-Author, "More Cannabis Industry Securities Suits Hit Dockets," Legal Update, Seyfarth Shaw LLP (May 25, 2021)
- Co-Author, "New York’s Disclosure Law and Other Laws and Regulatory Mandates Regarding Women on Corporate Boards," Legal Update, Seyfarth Shaw LLP (January 21, 2021)
- Co-Author, "Over 50 M&A Deals Have Been Challenged This Year by a Single Group of Lawyers," Legal Update, Seyfarth Shaw LLP (June 12, 2020)
- Co-Author, "Event-Driven Securities Litigation in the Age of COVID-19," Legal Update, Seyfarth Shaw LLP (June 11, 2020)
- Co-Author, "District Courts In New Jersey And New York Dismiss Securities Class Actions Against Life Science Companies Emphasizing the High Pleading Bar With Respect To Optimistic Forward-Looking Statements," Legal Update, Seyfarth Shaw LLP (May 5, 2020)
- Co-Author, "Ninth Circuit To Determine Applicability of Affiliated Ute Presumption of Reliance To Securities Fraud Actions," Legal Update, Seyfarth Shaw LLP (April 17, 2020)
- Co-Author, "Massachusetts District Court Dismisses Suit Against Pharma Company Finding That Optimistic Statements Regarding Drug Prospects Are Not Misleading Simply Because FDA Does Not Approve," Legal Update, Seyfarth Shaw LLP (April 14, 2020)
- Co-Presenter, "Commercial Litigation Outlook: Part 1: Insights and Predictions for Litigation Trends in 2022," Webinar Series, Seyfarth Shaw LLP (April 12, 2022)
- Panelist, "Crisis Management and Workplace Investigations Planning and Response," Webinar, Seyfarth Shaw LLP (September 30, 2021)
- Co-Presenter, "New Era, New Litigation: Lawsuits You Can Expect in the Post-Pandemic Environment," Webinar, Seyfarth Shaw LLP (July 22, 2020)
- Co-Presenter, "COVID-19 Legal Exposure for Public Companies and their Directors & Officers," Webinar, Seyfarth Shaw LLP (April 21, 2020)